August 23, 2017
CTI Clinical Trial & Consulting Services Announces Michael Bahm Promoted to Vice President of Global Information Technologies
FOR IMMEDIATE RELEASE [Covington, KY ~ August 23, 2017]
CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization announces Michael Bahm has been promoted to Vice President, Global Information Technologies.
“Mike has been a crucial member of the CTI team for more than 17 years," says Maria Marsh, CFO. "We are proud to announce Mike's promotion, and we look forward to having him as a part of our team for many years to come."
Bahm has contributed to the growth and success of CTI since he joined the company in 2000. He is responsible for the Global IT department, including overseeing multiple systems, managing international cybersecurity, and acting as a mentor for his direct reports. Over the past 17 years, he has been instrumental in building our infrastructure from the ground-up and supporting our IT needs through many upgrades and improvements, new system implementations, corporate moves, global expansions, and acquisitions.
Bahm earned his Bachelor of Science in Business Administration Information Systems from Xavier University.
About CTI Clinical Trial and Consulting Services
CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com